DOI: 10.1128/JVI.01246-17
Article Information
PubMed
Published By
History
- Received July 20, 2017
- Accepted November 3, 2017
- Published online January 17, 2018.
Copyright & Usage
Copyright © 2018 Jere et al. This is an open-access article distributed under the terms of the Creative Commons Attribution 4.0 International license.
Editors and / or Reviewers
- Tom Gallagher, Editor, Loyola University Medical Center
Article Versions
- Accepted Manuscript version (November 15, 2017).
- You are viewing the most recent version of this article.
Author Information
- Khuzwayo C. Jerea,b,
- Chrispin Chaguzaa,b,
- Naor Bar-Zeeva,b,c,
- Jenna Lowea,
- Chikondi Penob,
- Benjamin Kumwendab,
- Osamu Nakagomia,d,
- Jacqueline E. Tatee,
- Umesh D. Parashare,
- Robert S. Heydermanb,f,
- Neil Frenchb,c,
- Nigel A. Cunliffec and
- Miren Iturriza-Gomarac,g
- for the VACSURV Consortium
- aInstitute of Infection and Global Health, University of Liverpool, Liverpool, United Kingdom
- bMalawi-Liverpool-Wellcome Trust Clinical Research Programme/Department of Medical Laboratory Sciences, College of Medicine, University of Malawi, Blantyre, Malawi
- cCentre for Global Vaccine Research, Institute of Infection and Global Health, University of Liverpool, Liverpool, United Kingdom
- dGraduate School of Biomedical Sciences, Nagasaki University, Nagasaki, Japan
- eEpidemiology Branch, Division of Viral Diseases, National Center for Immunization and Respiratory Diseases, Centers for Disease Control and Prevention, Atlanta, Georgia, USA
- fDivision of Infection and Immunity, University College London, London, United Kingdom
- gNIHR Health Protection Research Unit in Gastrointestinal Infections, University of Liverpool, Liverpool, United Kingdom
- Address correspondence to Khuzwayo C. Jere, Khuzwayo.Jere{at}liverpool.ac.uk.
N.A.C. and M.I.-G. contributed equally.
Citation Jere KC, Chaguza C, Bar-Zeev N, Lowe J, Peno C, Kumwenda B, Nakagomi O, Tate JE, Parashar UD, Heyderman RS, French N, Cunliffe NA, Iturriza-Gomara M, VACSURV Consortium. 2018. Emergence of double- and triple-gene reassortant G1P[8] rotaviruses possessing a DS-1-like backbone after rotavirus vaccine introduction in Malawi. J Virol 92:e01246-17. https://doi.org/10.1128/JVI.01246-17.
